Jwr. Mulder et al., EVALUATION OF P53 PROTEIN EXPRESSION AS A MARKER FOR LONG-TERM PROGNOSIS IN COLORECTAL-CARCINOMA, British Journal of Cancer, 71(6), 1995, pp. 1257-1262
Mutation of the p53 gene is reported to be of prognostic importance in
colorectal carcinomas. Immunohistochemical staining of the accumulate
d p53 gene product may be a simple alternative for p53 mutation analys
is. Previous studies addressing the prognostic importance of p53 expre
ssion, however, yielded contradictory results. Therefore, we evaluated
the importance of p53 expression as a marker for long-term prognosis
in a well-characterised study population of 109 colorectal carcinomas.
After antigen retrieval with target unmasking fluid (TUF), immunostai
ning of p53 was performed with both monoclonal antibody DO7 and polycl
onal antibody CM1. Objective quantification of the p53 signal was asse
ssed by a computerised image analyser. p53 expression was higher in no
n-mucinous tumours than in mucinous rumours (p53 labelling index = 30%
and 17% respectively, P = 0.05), and in metastatic tumours compared w
ith non-metastatic tumours (p53 labelling index = 37% and 22% respecti
vely, P = 0.05). Other histopathological features were not related to
p53 expression. In multivariate analysis, Dukes' stage (P = 0.02) and
histological grade (P = 0.05) stood out as independent markers for pro
gnosis. p53 expression was not an independent marker for prognosis. At
present, p53 expression is not a useful marker for long-term prognosi
s. Further insight into the relationship between p53 mutations and p53
expression is needed to elucidate more precisely the clinical relevan
ce of p53 alterations.